Related Experiment Video
Updated: Aug 13, 2026

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
Published on: August 15, 2019
The single nucleotide polymorphism IVS1+309 in mouse double minute 2 does not affect risk of familial breast cancer
Stefan Wilkening1, Justo Lorenzo Bermejo, Barbara Burwinkel
1Department of Molecular Genetic Epidemiology, German Cancer Research Center (Deutsches Krebsforschungszentrum), Im Neuenheimer Feld 580, 69120 Heidelberg, Germany. s.wilkening@dkfz.de
Abstract:
The mouse double minute 2 (MDM2) oncoprotein promotes cell survival and cell cycle progression by inhibiting the p53 tumor suppressor protein. Further, MDM2 overexpression can inhibit DNA double-strand break repair in a p53-independent manner. Recently, it was shown that a single nucleotide polymorphism (SNP) in the MDM2 promoter was associated with an accelerated tumor formation in individuals with a p53 mutation. The present case-control study investigated the association of this SNP (IVS1+309) with the risk and the age of onset of familial breast cancer in patients with unknown p53 mutation status. Data from 549 women affected by familial breast cancer and 1,065 healthy controls were analyzed. The cases did not carry BRCA1/2 mutations. Cases and controls showed a similar genotype distribution and the SNP did not seem to modify the age of onset of familial breast cancer. The data were also examined taking into account the presence of any additional cancer after breast cancer and the family history of cases; however, no association was found. These results suggest that the SNP IVS1+309 alone affects neither the risk nor the age of onset of heritable breast cancer.
Insights
This study found that a specific genetic variation in the mouse double minute 2 (MDM2) gene promoter, known as IVS1+309, does not increase the risk or alter the age of onset for familial breast cancer in women without BRCA1/2 mutations.
Area of Science:
- Genetics
- Oncology
- Molecular Biology
Background:
- The mouse double minute 2 (MDM2) oncoprotein is crucial for cell survival and progression by inhibiting the p53 tumor suppressor.
- MDM2 overexpression can impair DNA double-strand break repair independently of p53.
- A prior study linked an MDM2 promoter single nucleotide polymorphism (SNP) to faster tumor development in individuals with p53 mutations.
Purpose of the Study:
- To investigate the association between the MDM2 IVS1+309 SNP and the risk of familial breast cancer.
- To examine if this SNP influences the age of onset in familial breast cancer patients.
- To analyze the SNP's role in hereditary breast cancer, excluding BRCA1/2 mutations and considering p53 mutation status as unknown.
Main Methods:
- A case-control study design was employed.
- Data from 549 women with familial breast cancer (negative for BRCA1/2 mutations) and 1,065 healthy controls were analyzed.
- Genotype distribution of the IVS1+309 SNP was compared between cases and controls.
Main Results:
- No significant difference in genotype distribution was observed between familial breast cancer cases and controls.
- The IVS1+309 SNP did not demonstrate a modifying effect on the age of onset for familial breast cancer.
- Further analysis considering additional cancers or family history did not reveal any association with the SNP.
Conclusions:
- The MDM2 IVS1+309 SNP, in isolation, does not appear to influence the risk or age of onset of heritable breast cancer in the absence of BRCA1/2 mutations.
- These findings suggest that this specific genetic variation may not be a significant risk factor for this subset of familial breast cancer.
- Further research might be needed to explore potential interactions with other genetic or environmental factors.
Related Concept Videos
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
In-vitro Mutagenesis
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Single Nucleotide Polymorphisms-SNPs

